1. Home
  2. BVS vs NMAI Comparison

BVS vs NMAI Comparison

Compare BVS & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • NMAI
  • Stock Information
  • Founded
  • BVS 2011
  • NMAI 2021
  • Country
  • BVS United States
  • NMAI United States
  • Employees
  • BVS N/A
  • NMAI N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NMAI Investment Managers
  • Sector
  • BVS Health Care
  • NMAI Finance
  • Exchange
  • BVS Nasdaq
  • NMAI Nasdaq
  • Market Cap
  • BVS 496.7M
  • NMAI 422.8M
  • IPO Year
  • BVS 2021
  • NMAI N/A
  • Fundamental
  • Price
  • BVS $6.46
  • NMAI $12.29
  • Analyst Decision
  • BVS Strong Buy
  • NMAI
  • Analyst Count
  • BVS 4
  • NMAI 0
  • Target Price
  • BVS $15.00
  • NMAI N/A
  • AVG Volume (30 Days)
  • BVS 325.5K
  • NMAI 74.8K
  • Earning Date
  • BVS 08-05-2025
  • NMAI 01-01-0001
  • Dividend Yield
  • BVS N/A
  • NMAI 13.14%
  • EPS Growth
  • BVS N/A
  • NMAI N/A
  • EPS
  • BVS N/A
  • NMAI 0.64
  • Revenue
  • BVS $567,699,000.00
  • NMAI N/A
  • Revenue This Year
  • BVS N/A
  • NMAI N/A
  • Revenue Next Year
  • BVS $6.11
  • NMAI N/A
  • P/E Ratio
  • BVS N/A
  • NMAI $19.03
  • Revenue Growth
  • BVS 8.60
  • NMAI N/A
  • 52 Week Low
  • BVS $5.28
  • NMAI $10.60
  • 52 Week High
  • BVS $14.38
  • NMAI $12.55
  • Technical
  • Relative Strength Index (RSI)
  • BVS 43.37
  • NMAI 47.39
  • Support Level
  • BVS $6.32
  • NMAI $12.21
  • Resistance Level
  • BVS $7.08
  • NMAI $12.68
  • Average True Range (ATR)
  • BVS 0.23
  • NMAI 0.13
  • MACD
  • BVS 0.02
  • NMAI -0.05
  • Stochastic Oscillator
  • BVS 25.00
  • NMAI 16.67

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest

Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment strategy uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.

Share on Social Networks: